Acitretin, bearing the CAS number 55079-83-9, stands as a significant compound in the pharmaceutical landscape, particularly as a pharmaceutical intermediate for advanced dermatological therapies. Its chemical structure, a synthetic retinoid, endows it with the ability to modulate cellular processes critical for skin health. This makes it invaluable for the treatment of severe skin conditions like psoriasis.

The clinical significance of Acitretin is rooted in its mechanism of action: normalizing the skin's natural growth and differentiation cycles. For patients suffering from psoriasis, where these cycles are disrupted, Acitretin offers a pathway to symptom relief by reducing inflammation and scaling. The precision required in synthesizing and handling such a potent intermediate is a hallmark of responsible pharmaceutical manufacturing.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to producing Acitretin that adheres to the highest standards of purity and quality. This commitment ensures that the compound can be effectively used in the formulation of safe and efficacious dermatological treatments. Understanding the complete profile of Acitretin, including its pharmacokinetic properties and potential drug interactions, is essential for its successful application. The company also emphasizes the critical importance of addressing acitretin adverse effects and its known teratogenic properties, which demand strict adherence to safety protocols.

The consistent supply of high-grade Acitretin by NINGBO INNO PHARMCHEM CO.,LTD. empowers pharmaceutical researchers and developers to create innovative solutions for patients with significant dermatological needs. By focusing on both the chemical integrity and the clinical implications of this vital intermediate, the company contributes to the advancement of skin therapy.